Corcept Therapeutics Overview
Latest P/E ratio for Corcept Therapeutics: 220.17 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow220.17
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, CORT shows a P/E ratio of 220.17. That is above the Healthcare sector average of 27.42. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 27.42. Corcept Therapeutics is at 220.17, which is higher that average. That is roughly 702.8% above the sector mean. Use the comparison chart on this page to see how CORT stacks up against individual peers as well.
Investors watch CORT's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Corcept Therapeutics's latest reading is 220.17. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Corcept Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 220.17) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 27.42, while CORT is at 220.17. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
